Media Welcome to Guerbet Media section for journalists. The press releases are intended for their professional use. Find our latest press releases and our media resources. Media… Homepage Media Our Latest Press Releases Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT Read the article Changes to the Composition of Guerbet’s Board of Directors Read the article Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil) Read the article - Any - 2026 2025 2024 2023 2022 2021 2020 2019 2018 ApplyClear Filters Revenue on September 30, 2022 Read the article Guerbet obtains one million euros of public funding from Bpifrance (France 2030 investment plan) for a project developing artificial intelligence for the early detection of pancreatic cancer Read the article 2022 half-year results Read the article H1 2022 sales Read the article Guerbet receives EMA acceptance of Elucirem™ as the Brand Name for Gadopiclenol. Read the article Q1 2022 sales Read the article Gadopiclenol Marketing Authorization dossier submissions accepted for review by EMA and FDA Read the article Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolization Read the article 2021 revenue Read the article ‹ 2 3 4 5 Current page6 7 8 9 10 ›
Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT Read the article
Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil) Read the article
Guerbet obtains one million euros of public funding from Bpifrance (France 2030 investment plan) for a project developing artificial intelligence for the early detection of pancreatic cancer Read the article
Gadopiclenol Marketing Authorization dossier submissions accepted for review by EMA and FDA Read the article
Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolization Read the article
